Research ArticleOriginal Article
Open Access

Voiding dysfunction in children causes, management, and prognosis

A single-center retrospective study

Sherif M. El Desoky, Mai Banakhar, Khalid Khashoggi, Zaher F. Zaher and Jameela A. Kari
Saudi Medical Journal August 2021, 42 (8) 869-877; DOI: https://doi.org/10.15537/smj.2021.42.8.20210327

References

  1. 1.↵
    1. Müller T,
    2. Arbeiter K,
    3. Aufricht C.
    Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol 2002; 12: 479–484.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Bauer SB.
    Neurogenic bladder: etiology and assessment. Pediatr Nephrol 2008; 23: 541–551.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Palomaki GE,
    2. Williams JR,
    3. Haddow JE.
    Prenatal screening for open neural-tube defects in Maine. N Engl J Med 1999; 340: 1049–1050.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Chase J,
    2. Austin P,
    3. Hoebeke P,
    4. McKenna P.
    The management of dysfunctional voiding in children: a report from the standardisation committee of the international children’s continence society. J Urol 2010; 183: 1296–1302.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Sturm RM,
    2. Cheng EY.
    The management of the pediatric neurogenic bladder. Curr Bladder Dysfunct Rep 2016; 11: 225–233.
    OpenUrlCrossRef
  6. 6.↵
    1. Jayanthi VR,
    2. Khoury AE,
    3. McLorie GA,
    4. Agarwal SK.
    The nonneurogenic neurogenic bladder of early infancy. J Urol 1997; 158: 1281–1285.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Nevéus T,
    2. von Gontard A,
    3. Hoebeke P,
    4. Hjälmås K,
    5. Bauer S,
    6. Bower W, et al.
    The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardisation committee of the international children’s continence society. J Urol 2006; 176: 314–324.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Taskinen S,
    2. Heikkilä J,
    3. Rintala R.
    Effects of posterior urethral valves on long-term bladder and sexual function. Nat Rev Urol 2012; 9: 699–706.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Schwartz GJ,
    2. Muñoz A,
    3. Schneider MF,
    4. Mak RH,
    5. Kaskel F,
    6. Warady BA, et al.
    New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629–637.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Kari JA.
    Neuropathic bladder as a cause of chronic renal failure in children in developing countries. Pediatr Nephrol 2006; 21: 517–520.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Proesmans W.
    The neurogenic bladder: introducing four contributions. Pediatr Nephrol 2008; 23: 537–540.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Safdar OY,
    2. Al-Dabbagh AA,
    3. Abuelieneen WA,
    4. Kari JA.
    Decline in the incidence of neural tube defects after the national fortification of flour (1997-2005). Saudi Med J 2007; 28: 1227–1229.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Hinman F,
    2. Baumann FW.
    Vesical and ureteral damage from voiding dysfunction in boys without neurologic or obstructive disease. J Urol 2017; 197: S127–S131.
    OpenUrl
  14. 14.↵
    1. Allen TD.
    Forty years experience with voiding dysfunction. BJU Int 2003; 92: 15–22.
    OpenUrl
  15. 15.↵
    1. Al Mosawi AJ.
    Identification of nonneurogenic neurogenic bladder in infants. Urology 2007; 70: 355–356.
    OpenUrlPubMed
  16. 16.↵
    1. Avlan D,
    2. Gündoğdu G,
    3. Taşkınlar H,
    4. Delibaş A,
    5. Naycı A.
    Relationships among vesicoureteric reflux, urinary tract infection and renal injury in children with non-neurogenic lower urinary tract dysfunction. J Pediatr Urol 2011; 7: 612–615.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Hoebeke P,
    2. Van Laecke E,
    3. Van Camp C,
    4. Raes A,
    5. Van De Walle J.
    One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int 2001; 87: 575–580.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Kari JA,
    2. Safdar O,
    3. Jamjoom R,
    4. Anshasi W.
    Renal involvement in children with spina bifida. Saudi J Kidney Dis Transpl 2009; 20: 102–105.
    OpenUrlPubMed
  19. 19.↵
    1. Dik P,
    2. Klijn AJ,
    3. van Gool JD,
    4. de Jong-de Vos van Steenwijk CC,
    5. de Jong TP
    . Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 2006; 49: 908–913.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Dorsher PT,
    2. McIntosh PM.
    Neurogenic bladder. Adv Urol 2012; 2012: 816274.
    OpenUrlPubMed
  21. 21.↵
    1. Maison POM,
    2. Lazarus J.
    The management of paediatric neurogenic bladder: an approach in a resource-poor setting. Paediatr Int Child Health 2017; 37: 280–285.
    OpenUrl
  22. 22.↵
    1. Lapides J,
    2. Diokno AC,
    3. Silber SJ,
    4. Lowe BS
    . Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 2017; 197: S122–S124.
    OpenUrl
  23. 23.↵
    1. Kari JA,
    2. El-Desoky S,
    3. Farag YM,
    4. Mosli H,
    5. Altyieb AM,
    6. Al Sayad A, et al.
    Renal impairment in children with posterior urethral valves. Pediatr Nephrol 2013; 28: 927–931.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Bilgutay AN,
    2. Roth DR,
    3. Gonzales ET Jr.,
    4. Janzen N,
    5. Zhang W,
    6. Koh CJ, et al.
    Posterior urethral valves: risk factors for progression to renal failure. J Pediatr Urol 2016; 12: 179.
    OpenUrl
  25. 25.↵
    1. Close CE,
    2. Carr MC,
    3. Burns MW,
    4. Mitchell ME.
    Lower urinary tract changes after early valve ablation in neonates and infants: is early diversion warranted? J Urol 1997; 157: 984–988.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Peters CA,
    2. Bolkier M,
    3. Bauer SB,
    4. Hendren WH,
    5. Colodny AH,
    6. Mandell J, et al.
    The urodynamic consequences of posterior urethral valves. J Urol 1990; 144: 122–126.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Nasir AA,
    2. Ameh EA,
    3. Abdur-Rahman LO,
    4. Adeniran JO,
    5. Abraham MK.
    Posterior urethral valve. World J Pediatr 2011; 7: 205–216.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Duckett JW.
    Are ‘valve bladders’ congenital or iatrogenic? Br J Urol 1997; 79: 271–275.
    OpenUrlPubMed
  29. 29.↵
    1. Mehmood S,
    2. Seyam R,
    3. Firdous S,
    4. Altaweel WM.
    Factors predicting renal function outcome after augmentation cystoplasty. Int J Nephrol 2017; 2017: 3929352.
    OpenUrl
  30. 30.↵
    1. Husmann DA.
    Long-term complications following bladder augmentations in patients with spina bifida: bladder calculi, perforation of the augmented bladder and upper tract deterioration. Transl Androl Urol 2016; 5: 3–11.
    OpenUrl
  31. 31.↵
    1. Marte A,
    2. Borrelli M,
    3. Prezioso M,
    4. Pintozzi L,
    5. Parmeggiani P.
    Efficacy and safety of botulinum toxin A for treating bladder hyperactivity in children and adolescents with neuropathic bladder secondary to myelomeningocele. Dataset Papers in Medicine 2013; 2013: 1–5.
    OpenUrl
  32. 32.↵
    1. Kari JA,
    2. El Desoky SM,
    3. Farag YM,
    4. Singh AK.
    Predictors of renal replacement therapy and mortality in children with chronic kidney disease. Saudi Med J 2015; 36: 32–39.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. McLeod DJ,
    2. Szymanski KM,
    3. Gong E,
    4. Granberg C,
    5. Reddy P,
    6. Sebastião Y, et al.
    Renal replacement therapy and intermittent catheterization risk in posterior urethral valves. Pediatrics 2019; 143: e20182656.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Saeed B.
    Pediatric versus adult kidney transplantation activity in Arab countries. Saudi J Kidney Dis Transpl 2013; 24: 1031–1038.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords